The complete study cohort includes 1,023 patients from 22 sites in Europe.

The appointment gives a former Abbott leader oversight of efforts to bring a pulsed field ablation device to market.

J&J Medtech has launched the latest version of its pulsed ablation device after receiving CE Mark approval in Europe. The ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.

The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European ...

Pulsed field ablation (PFA), a technology now approved in Europe but not yet licensed in the United States, achieved noninferiority to conventional thermal ablation for the treatment of atrial ...

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...

“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...

CINCINNATI (WKRC) - Cardiologists at TriHealth Heart and Vascular Institute are among the first in the nation to use a new device that corrects heart rhythm. The device goes inside the heart. It then ...

Radiofrequency (RF) catheter ablation has been a standout success in some forms of atrial fibrillation (AF) but not an unqualified success — it doesn't always work and has safety issues and other ...

CHICAGO (Reuters) - Johnson & Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S. regulatory approval for ...